Transcranial Magnetic Stimulation in Depression - Full Text View

Transcranial Magnetic Stimulation in Depression

This study has been completed.

Sponsored by:	Department of Veterans Affairs
Information provided by:	Department of Veterans Affairs
ClinicalTrials.gov Identifier:	NCT00018746

Purpose

The study examines efficacy of repetitive transcranial magnetic stimulation in treating severely depressed patients who are medicated.

Condition	Intervention	Phase
Depression	Device: repetitive transcranial magnetic stimulation	Phase I

MedlinePlus related topics:

Depression

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Treatment, Randomized, Single Blind, Placebo Control, Crossover Assignment, Efficacy Study

Official Title:	Efficacy of Threshold Vs. Subthreshold TMS in the Treatment of Depression

Further study details as provided by Department of Veterans Affairs:

Study Start Date:	July 1999
Estimated Study Completion Date:	July 2001

Detailed Description:

Medicated, treatment resistant, depressed patients are randomized to active or sham repetitive transcranial magnetic stimulation (rTMS). Responding patients go into a six months follow-up period.

Eligibility

Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

severe treatment-resistant depression

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00018746

Locations


United States, Connecticut
	VA Connecticut Healthcare System
	West Haven, Connecticut, United States, 06516

Sponsors and Collaborators

Department of Veterans Affairs

Investigators


Investigator:	Ralph Hoffman

Investigator:	Dan Oren

More Information

Study ID Numbers:	MHBS-037-98S
First Received:	July 3, 2001
Last Updated:	June 23, 2005
ClinicalTrials.gov Identifier:	NCT00018746
Health Authority:	United States: Food and Drug Administration

Study placed in the following topic categories:

Depression

Mental Disorders

Mood Disorders

Depressive Disorder

Behavioral Symptoms

ClinicalTrials.gov processed this record on November 20, 2008